Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

vanadyl sulfate

Known as: VOSO4, oxosulfatovanadium(IV) 
 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Hypoglycemic AgentsVanadium Compounds
vanadyl sulfate 10 MG

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.
BACKGROUND Vanadyl sulfate (VS) and taurine are two promising agents in the treatment of diabetes related to their… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats.
Diabetes mellitus is a significant risk factor for cardiovascular complications. Experimental evidence suggests that oxidative… Expand
Is this relevant?
2005
2005
Vanadyl Sulfate Administration Protects the Streptozotocin-Induced Oxidative Damage to Brain Tissue in Rats
Diabetes mellitus manifests itself in a wide variety of complications and the symptoms of the disease are multifactorial. The… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2005
2005
Protective effect of vanadyl sulfate on the pancreas of streptozotocin-induced diabetic rats.
The aim of this study is to examine from a biochemical and histological perspective, whether vanadium has a protective effect on… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.
Vanadyl sulfate (VOSO(4)) is an oxidative form of vanadium that in vitro and in animal models of diabetes has been shown to… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
To investigate the efficacy and mechanism of action of vanadium salts as oral hypoglycemic agents, 16 type 2 diabetic patients… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
The safety and efficacy of vanadyl sulfate (VS) was tested in a single-blind, placebo-controlled study. Eight patients (four men… Expand
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
We compared the effects of oral vanadyl sulfate (100 mg/day) in moderately obese NIDDM and nondiabetic subjects. Three-hour… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.
We examined the in vivo metabolic effects of vanadyl sulfate (VS) in non-insulin-dependent diabetes mellitus (NIDDM). Six NIDDM… Expand
  • figure 1
  • table I
  • table II
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1989
Highly Cited
1989
Oral vanadyl sulfate in treatment of diabetes mellitus in rats.
Recent reports have suggested that vanadium in the form of vanadyl (+IV) possesses insulin-like activity. Therefore, in the… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE